DiGeorge Syndrome Critical Region Gene 8 (DGCR8) Peptid
DGCR8
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN937407
Kurzübersicht für DiGeorge Syndrome Critical Region Gene 8 (DGCR8) Peptid (ABIN937407)
Target
DGCR8
(DiGeorge Syndrome Critical Region Gene 8 (DGCR8))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- DKKDEENELD QEKRVEYAVL DELEDFTDNL ELDEEGAGGF TAKAIVQRDR
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of DGCR8 antibody,
Alternative Names: DGCR8 control peptide, DGCR8 antibody Blocking Peptide, Anti-DGCR8 Blocking Peptide, Digeorge Syndrome Critical Region Gene 8 Blocking Peptide, C22orf12 Blocking Peptide, DGCRK6 Blocking Peptide, Gy1 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- DGCR8 (DiGeorge Syndrome Critical Region Gene 8 (DGCR8))
-
Hintergrund
- DGCR8 contains 2 DRBM (double-stranded RNA-binding) domains and 1 WW domain. It may play a part in the etiology of the velocardiofacial/DiGeorge syndrome (VCFS/DGS), a developmental disorder characterized by structural and functional palate anomalies, conotruncal cardiac malformations, immunodeficiency, hypocalcemia, and typical facial anomalies.
-
Molekulargewicht
- 85 kDa
Target
-
Sie sind hier:
